Stephen Yoo is Chief Medical Officer at REGENXBIO Inc. (RGNX). They have made 10 open-market trades across 1 company since 2017, most recently 2018-12-03.
CIK 0001652825
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RGNX | 507 | $4K |
Shares reported on the most recent Form 4, priced at the 2018-12-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGNX | SELL | 2018-12-03 | 2018-12-06 | $60.11 | $2.4M | -16.9% | -18.7% | -4.4% |
| RGNX | SELL | 2018-11-19 | 2018-11-21 | $59.45 | $2.2M | -10.4% | -35.3% | -23.1% |
| RGNX | SELL | 2018-11-05 | 2018-11-07 | $68.29 | $2.5M | -17.6% | -27.9% | -35.2% |
| RGNX | SELL | 2018-10-29 | 2018-10-31 | $62.47 | $2.3M | -6.7% | -10.8% | -37.8% |
| RGNX | SELL | 2018-10-15 | 2018-10-17 | $60.58 | $1.9M | -2.4% | +4.7% | -29.0% |
| RGNX | SELL | 2017-09-08 | 2017-09-12 | $25.00 | $684K | +10.1% | +30.4% | +15.0% |
| RGNX | SELL | 2017-09-05 | 2017-09-07 | $25.00 | $816K | +17.8% | +31.0% | +19.5% |
| RGNX | SELL | 2017-08-21 | 2017-08-23 | $20.03 | $300K | +16.4% | +32.6% | +36.6% |
| RGNX | SELL | 2017-07-20 | 2017-07-24 | $18.66 | $280K | -6.2% | +8.2% | +59.9% |
| RGNX | SELL | 2017-06-20 | 2017-06-22 | $19.68 | $295K | -3.6% | -7.6% | +39.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.